Equitec Proprietary Markets’s Pfizer PFE Stock Holding History

Equitec Proprietary Markets’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,100	Closed	-$124K	–	377
2021 Q4	$124K	Buy	+2,100	New	+$104K	0.02%	142
2015 Q1	–	Sell	-59,953	Closed	-$1.77M	–	438
2014 Q4	$1.77M	Buy	+59,953	New	+$1.72M	0.08%	56

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Equitec Proprietary Markets's PFE Position: Q1 2022 in Review

Equitec Proprietary Markets sold out of Pfizer (PFE) in Q1 2022, closing a stake of 2,100 shares — an estimated $124K sold.

Equitec Proprietary Markets first reported a position in PFE in Q4 2014 and held it in 2 quarters. The position peaked at $1.77M in Q4 2014. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Equitec Proprietary Markets reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
Equitec Proprietary Markets sold 2,100 Pfizer shares in Q1 2022, an estimated $124K.
Equitec Proprietary Markets first reported a position in Pfizer in Q4 2014 and held it in 2 quarters.
Equitec Proprietary Markets's Pfizer position peaked at $1.77M in Q4 2014.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Equitec Proprietary Markets's 13F filing for Q1 2022, filed 22 Apr 2022.